0000899243-18-025192.txt : 20180925 0000899243-18-025192.hdr.sgml : 20180925 20180925180556 ACCESSION NUMBER: 0000899243-18-025192 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180921 FILED AS OF DATE: 20180925 DATE AS OF CHANGE: 20180925 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Milligan Peter J CENTRAL INDEX KEY: 0001531049 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35405 FILM NUMBER: 181086512 MAIL ADDRESS: STREET 1: 1650 TYSONS BOULEVARD STREET 2: SUITE 1700 CITY: MCLEAN STATE: VA ZIP: 22102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MELINTA THERAPEUTICS, INC. /NEW/ CENTRAL INDEX KEY: 0001461993 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 454440364 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 GEORGE STREET STREET 2: SUITE 301 CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 312 767 0291 MAIL ADDRESS: STREET 1: 300 GEORGE STREET STREET 2: SUITE 301 CITY: NEW HAVEN STATE: CT ZIP: 06511 FORMER COMPANY: FORMER CONFORMED NAME: CEMPRA, INC. DATE OF NAME CHANGE: 20120203 FORMER COMPANY: FORMER CONFORMED NAME: Cempra Holdings, LLC DATE OF NAME CHANGE: 20090414 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-09-21 0 0001461993 MELINTA THERAPEUTICS, INC. /NEW/ MLNT 0001531049 Milligan Peter J C/O MELINTA THERAPEUTICS, INC. 300 GEORGE STREET, SUITE 301 NEW HAVEN CT 06511 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 4.50 2018-09-21 4 A 0 370000 0.00 A 2028-09-21 Common Stock 370000 370000 D One-quarter of the options will vest and become exercisable on September 17, 2019 and the remainder will vest and become exercisable in substantially equal monthly installments during the three year period commencing on September 17, 2019, subject to Mr. Milligan's continued service with the Company through the applicable vesting date. /s/ Peter Milligan 2018-09-24